The standard case for the fund is to invest in rounds with 4 partakers. Despite the Fame Mount Limited, startups are often financed by ff Venture Capital, Rugged Ventures, Harrison Metal. The meaningful sponsors for the fund in investment in the same round are ff Venture Capital, Visual China Group, Suntech Power. In the next rounds fund is usually obtained by Vivo Capital, StartX (Stanford-StartX Fund), Northern Light Venture Capital.
The fund is constantly included in less than 2 deals per year. The important activity for fund was in 2017. Deals in the range of 5 - 10 millions dollars are the general things for fund. Comparing to the other companies, this Fame Mount Limited performs on 4 percentage points more the average number of lead investments. The higher amount of exits for fund were in 2018.
We can highlight the next thriving fund investment areas, such as Marketplace, Photography. Among the most popular portfolio startups of the fund, we may highlight Compute Software, Immune-Onc Therapeutics, 500px. The fund has exact preference in a number of founders of portfolio startups. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund.
Related Funds
| Fund Name | Location |
| Aderans | Japan, Tokyo |
| Ashoka | Arlington, United States, Virginia |
| Banco do Brasil | Brasília, Brazil, Rio Grande do Norte |
| Brizan Venture | - |
| Daiwa Logitech | Chiba Prefecture, Japan, Tateyama |
| KARAT | Hefa, Hefa, Israel |
| Ligand Pharmaceuticals | California, San Diego, United States |
| Live Shark Tank | - |
| New World Private Equity | England, London, United Kingdom |
| Novelion Therapeutics | British Columbia, Canada, Vancouver |
| Ohio TechAngels Fund | - |
| Savitr Capital | California, San Francisco, United States |
| Scientific Health Development Partners | Dallas, Texas, United States |
| Stow Capital | - |
| Ulmus Investment | - |
| Zhaoke Innovation | - |
| Zhuhai Hengqin Yicheng Guanli Zixun Qiye | China, Guangdong, Zhuhai |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Compute Software | $3M | 13 Sep 2017 | Mountain View, California, United States | ||
Immune-Onc Therapeutics | $7M | 01 Sep 2016 | Palo Alto, California, United States | ||
500px | $13M | 21 Jul 2015 | Old Toronto, Ontario, Canada |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Compute Software | $3M | 13 Sep 2017 | Mountain View, California, United States | ||
Immune-Onc Therapeutics | $7M | 01 Sep 2016 | Palo Alto, California, United States | ||
500px | $13M | 21 Jul 2015 | Old Toronto, Ontario, Canada |
